Mesenchymal stem cells biological properties and possibilities of clinical use
- Authors: Tatarinova O.S.1, Osipova E.Y.2, Roumiantsev S.A.2
-
Affiliations:
- Lomonosov Moscow state university
- Federal research center of pediatric hematology, oncology and immunology
- Issue: No 4 (2009)
- Pages: 33-44
- Section: ФУНДАМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ
- Published: 28.11.2009
- URL: https://oncohematology.abvpress.ru/ongm/article/view/784
- DOI: https://doi.org/10.17650/1818-8346-2009-0-4-33-44
- ID: 784
Cite item
Full Text
Abstract
Autologic and allogeneic mesenchymal stem cells (MSC) transplantation currently is used in clinical practice for hematopoietic progenitor engraftment acceleration and graft versus host disease prophylactic and treatment. In this literature review data concerning efficacy, safety and technologies of MSC clinical use are analyzed. Biological properties of MSC received in long-term culture and mechanisms of their interaction with other cells are discussed.
About the authors
O. S. Tatarinova
Lomonosov Moscow state university
Moscow
Russian FederationE. Yu. Osipova
Federal research center of pediatric hematology, oncology and immunology
Author for correspondence.
Email: e_ossipova@mail.ru
Moscow
Russian FederationS. A. Roumiantsev
Federal research center of pediatric hematology, oncology and immunology
Moscow
Russian FederationReferences
Supplementary files

